ImmunityBio: Anktiva Approval Opens Up A World Of Possibilities, Risks And Potential Gains
Thomas Barwick/DigitalVision via Getty ImagesInvestment Overview ImmunityBio (NASDAQ:IBRX), the San Diego-based biotech led by well-known biotech entrepreneur Dr. Patrick Soon-Shiong, was celebrating today as the company scored its first US drug …